Geetanjali Kapoor

Dr Geetanjali Kapoor is the Director of OHT, India. She is a physician, with specializations in medical microbiology and public health.

She served as the antimicrobial resistance (AMR) focal point for the implementation of the Fleming Fund Regional Grant in Africa (Mapping Antimicrobial Resistance and Antimicrobial Use Partnership), and has conducted capacity building workshops for African epidemiologists under the QWArS (Qualifying the workforce for AMR surveillance in Africa and Asia) program. Currently, she is leading a WHO study on landscape assessment of infectious disease surveillance systems in SEAR and developing clinical guidelines on optimization of medical oxygen.

Previously, she was involved in development of partnerships for expansion of OHT’s AMR database ResistanceMap, has co-authored “State of the World’s Antibiotics Report 2021,” and contributed to the “African antibiotic treatment guidelines for common bacterial infections and syndromes”. Dr Kapoor is a strategic advisory board member for the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) as well as a member of WHO’ bacterial priority pathogen advisory group.

Prior to joining OHT, Dr. Kapoor worked as a clinical microbiologist in India and Kuwait, and as a consultant at the World Health Organization. She contributed to India’s national infection prevention guidelines and state action plans for AMR control, and has provided strategic guidance to pharmaceutical firms on drug development.

Dr. Kapoor is a clinical microbiologist trained at Jawaharlal Nehru Medical College, Aligarh, India. She did her MPH from Johns Hopkins University, senior residency from AIIMS Delhi, Fellowship in General Infectious Diseases from Christian Medical College Vellore, and Hospital Management from India’s National Institute of Health and Family Welfare.

Her research interests are antimicrobial resistance surveillance, infectious disease and outbreak management, health systems strengthening, and health policy formulation.

Contact Geetanjali: [email protected]